| Name | RET-IN-22 |
|---|
| Description | RET-IN-22 (compound 17b) is a potent, selective and orally active RET inhibitor with an IC50 of 20.9 nM and 18.3 nM for wild-type RET and RET-V804M, respectively. RET-IN-22 shows highly selective profile to most kinases, especially to EGFR and VEGFR2. RET-IN-22 has anticancer effects[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 20.9 nM (wild-type RET) and 18.3 nM (RET-V804M)[1] |
| References |
| Molecular Formula | C29H31F3N6O4 |
|---|---|
| Molecular Weight | 584.59 |